1996	Foundation as a joint venture between Boehringer Mannheim and Science Park Raf to provide cell therapy services
1999	Acquisition of Boehringer Mannheim by Roche, which then sells its equity stake to EDCP venture capital fund
2000	Evolution of business model: from service company to biopharmaceutical product company
2002	Acquisition and incorporation of Genera S.p.A., the research company of the San Raffaele Institute
2004	Entrance of  three major Italian private investors: Fininvest, Herule Finance (now H-Equity S.r.l.) and La Leonardo Finanziaria (now Delfin S. à r.l.) as new shareholders, generating a capital increase of 20 million Euro
2006	Capital increase of 16 million Euro
2007	Capital increase of 10 million Euro
2008	IPO of 25% of shares, resulting in 56 million Euro of proceeds. Shares are traded on the Milan Stock Exchange since March 5, 2008